ANI Pharmaceuticals, Inc. - Common Stock — 재무제표 (NASDAQ:ANIP) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 461.19 M771.6 M760.09 M904.42 M1.28 B1.44 B 총 부채 265.49 M412.86 M421.55 M446.82 M855.17 M899.65 M 자본금 총액 195.7 M333.89 M313.69 M432.75 M403.68 M540.72 M 총 부채 및 주주자본 461.19 M771.6 M760.09 M904.42 M1.28 B1.44 B 총부채 172.44 M286.52 M285.67 M284.82 M309.11 M309.21 M 순부채 172.44 M286.52 M285.67 M284.82 M309.11 M6.25 M

뉴스

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term

ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook

ANIP Valuation: Does 9.8x Forward P/E Offer Upside?

ANIP Stock: What's Driving Cortrophin Gel's 2026 Surge

ANI Pharmaceuticals (ANIP) is a Top-Ranked Momentum Stock: Should You Buy?

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

Zacks.com featured highlights include ANI, Cummins and Seadrill

3 Stocks Showing Powerful Earnings Acceleration This May

ANI Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ANIP) 2026-05-08

ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) Reports Q1 Loss, Lags Revenue Estimates